Octaarginine-modified multifunctional envelope-type nano device for siRNA

Journal of Controlled Release

Volumn 119, Issue 3, 2007, Pages 360-367

  Nakamura, Yoshio ^a   Kogure, Kentaro ^a   Futaki, Shiroh ^b   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Liposomes; Multifunctional envelope type nano device; Non viral delivery system; Octaarginine; siRNA

Indexed keywords

CYTOTOXICITY; DNA; ENZYME ACTIVITY; GENE TRANSFER; LIPOSOMES; RNA;

GENE DELIVERY SYSTEMS; MULTIFUNCTIONAL ENVELOPES; NON VIRAL DELIVERY SYSTEMS; OCTAARGININE;

BIOMEDICAL EQUIPMENT;

ARGININE; LIPID; LUCIFERASE; OLIGONUCLEOTIDE; POLYCATION; POLYLYSINE; PROTAMINE; REAGENT; SMALL INTERFERING RNA;

ARTICLE; CELL NUCLEUS; CYTOPLASM; CYTOSOL; CYTOTOXICITY; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; METHODOLOGY; NANODEVICE; NONVIRAL GENE DELIVERY SYSTEM; POLYMERIZATION; PRIORITY JOURNAL; SCREENING; ZETA POTENTIAL;

DRUG COMPOUNDING; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; LUCIFERASES; MICROSCOPY, CONFOCAL; NANOSTRUCTURES; OLIGOPEPTIDES; POLYLYSINE; PROTAMINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 34248644581     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.03.010     Document Type: Article

References (40)

1. Bertrand J.R., Pottier M., Vekris A., Opolon P., Maksimenko A., and Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296 4 (2002) 1000-1004
2. Vickers T.A., Koo S., Bennett C.F., Crooke S.T., Dean N.M., and Baker B.F. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278 9 (2003) 7108-7118
3. Chen X., Dudgeon N., Shen L., and Wang J.H. Chemical modification of gene silencing oligonucleotides for drug discovery and development. Drug Discov. Today 10 8 (2005) 587-593
4. Hiroi N., Funahashi A., and Kitano H. Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA. Cancer Gene Ther. 13 1 (2006) 7-12
5. Scherer L., and Rossi J.J. Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21 12 (2003) 1457-1465
6. Scherer L., and Rossi J.J. RNAi applications in mammalian cells. BioTechniques 36 4 (2004) 557-561
7. Colin M., Maurice M., Trugnan G., Kornprobst M., Harbottle R.P., Knight A., Cooper R.G., Miller A.D., Capeau J., Coutelle C., and Brahimi-Horn M.C. Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells. Gene Ther. 7 2 (2000) 139-152
8. Verma U.N., Surabhi R.M., Schmaltieg A., Becerra C., and Gaynor R.B. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer Res. 9 4 (2003) 1291-1300
9. Dalby B., Cates S., Harris A., Ohki E.C., Tilkins M.L., Price P.J., and Ciccarone V.C. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods 33 2 (2004) 95-103
10. Bollerot K., Sugiyama D., Escriou V., Gautier R., Tozer S., Scherman D., and Jaffredo T. Widespread lipoplex-mediated gene transfer to vascular endothelial cells and hemangioblasts in the vertebrate embryo. Dev. Dyn. 235 1 (2006) 105-114
11. Dykxhoorn D.M., Palliser D., and Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Ther. 13 6 (2006) 541-552
12. Khoury M., Louis-Plence P., Escriou V., Noel D., Largeau C., Cantos C., Scherman D., Jorgensen C., and Apparailly F. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheum. 54 6 (2006) 1867-1877
13. Akita H., Ito R., Khalil I.A., Futaki S., and Harashima H. Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Mol. Ther. 9 3 (2004) 443-451
14. Leng Q., Scaria P., Zhu J., Ambulos N., Campbell P., and Mixson A.J. Highly branched HK peptides are effective carriers of siRNA. J. Gene Med. 7 7 (2005) 977-986
15. Grzelinski M., Urban-Klein B., Martens T., Lamszus K., Bakowsky U., Hobel S., Czubayko F., and Aigner A. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum. Gene Ther. 17 7 (2006) 751-766
16. Li S.D., and Huang L. Surface-modified LPD nanoparticles for tumor targeting. Ann. N. Y. Acad. Sci. 1082 (2006) 1-8
17. Hanai K., Takeshita F., Honma K., Nagahara S., Maeda M., Minakuchi Y., Sano A., and Ochiya T. Atelocollagen-mediated systemic DDS for nucleic acid medicines. Ann. N. Y. Acad. Sci. 1082 (2006) 9-17
18. Matsui K., Horiuchi S., Sando S., Sera T., and Aoyama Y. RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activity. Bioconjug. Chem. 17 1 (2006) 132-138
19. S. Veldhoen, S.D. Laufer, A. Trampe, T. Restle, Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: Quantitative analysis of uptake and biological effect. Nucleic Acids Res. (in press).
20. I.A. Khalil1, K. Kogure, S. Futaki, S. Hama, H. Akita, M. Ueno, H. Kishida, M. Kudoh, Y. Mishina, K. Kataoka, M. Yamada, H. Harashima, Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery. Gene Ther. (in press).
21. Kogure K., Moriguchi R., Sasaki K., Ueno M., Futaki S., and Harashima H. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J. Control. Release 98 2 (2004) 317-323
22. *-fusion method. Int. J. Pharm. 296 1-2 (2005) 142-150
23. Moriguchi R., Kogure K., Akita H., Futaki S., Miyagishi M., Taira K., and Harashima H. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. Int. J. Pharm. 301 1-2 (2005) 277-285
24. Yamada Y., Kogure K., Nakamura Y., Inoue K., Akita H., Nagatsugi F., Sasaki S., Suhara T., and Harashima H. Development of efficient packaging method of oligodeoxynucleotides by a condensed nano particle in lipid envelope structure. Biol. Pharm. Bull. 28 10 (2005) 1939-1942
25. Nakamura Y., Kogure K., Yamada Y., Futaki S., and Harashima H. Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide. J. Pharm. Pharmacol. 58 4 (2006) 431-437
26. Kamiya H., Akita H., and Harashima H. Pharmacokinetic and pharmacodynamic considerations in gene therapy. Drug Discov. Today 8 21 (2003) 990-996
27. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., and Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276 8 (2001) 5836-5840
28. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., Harashima H., and Sugiura Y. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug. Chem. 12 6 (2001) 1005-1011
29. Nakase I., Niwa M., Takeuchi T., Sonomura K., Kawabata N., Koike Y., Takehashi M., Tanaka S., Ueda K., Simpson J.C., Jones A.T., Sugiura Y., and Futaki S. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10 6 (2004) 1011-1022
30. Khalil I.A., Kogure K., Futaki S., and Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J. Biol. Chem. 281 6 (2006) 3544-3551
31. Khalil I.A., Futaki S., Niwa M., Baba Y., Kaji N., Kamiya H., and Harashima H. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. Gene Ther. 11 7 (2004) 636-644
32. Heyes J., Palmer L., Bremner K., and MacLachlan I. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J. Control Release 107 2 (2005) 276-287
33. Morrissey D.V., Lockridge J.A., Shaw L., Blanchard K., Jensen K., Breen W., Hartsough K., Machemer L., Radka S., Jadhav V., Vaish N., Zinnen S., Vargeese C., Bowman K., Shaffer C.S., Jeffs L.B., Judge A., MacLachlan I., and Polisky B. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23 8 (2005) 1002-1007
34. Zimmermann T.S., Lee A.C., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., Harborth J., Heyes J.A., Jeffs L.B., John M., Judge A.D., Lam K., McClintock K., Nechev L.V., Palmer L.R., Racie T., Rohl I., Seiffert S., Shanmugam S., Sood V., Soutschek J., Toudjarska I., Wheat A.J., Yaworski E., Zedalis W., Koteliansky V., Manoharan M., Vornlocher H.P., and MacLachlan I. RNAi-mediated gene silencing in non-human primates. Nature 441 7089 (2006) 111-114
35. Geisbert T.W., Hensley L.E., Kagan E., Yu E.Z., Geisbert J.B., Daddario-DiCaprio K., Fritz E.A., Jahrling P.B., McClintock K., Phelps J.R., Lee A.C., Judge A., Jeffs L.B., and MacLachlan I. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J. Infect. Dis. 193 12 (2006) 1650-1657
36. Judge A.D., Bola G., Lee A.C., and MacLachlan I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13 3 (2006) 494-505
37. Zhang C., Tang N., Liu X., Liang W., Xu W., and Torchilin V.P. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene. J. Control Release 112 2 (2006) 229-239
38. Happ C.S., Happ E., Nilges M., Gronenborn A.M., and Clore G.M. Refinement of the solution structure of the ribonucleotide 5′r(GCAUGC)2: combined use of nuclear magnetic resonance and restrained molecular dynamics. Biochemistry 27 5 (1988) 1735-1743
39. Blackburn G.M. DNA and RNA structure. In: Blackburn G.M., and Gait M.J. (Eds). Nucleic Acids in Chemistry and Biology (1989), IRL PRESS, Oxford 17-70
40. Tönges L., Lingor P., Egle R., Dietz G.P., Fahr A., and Bahr M. Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons. RNA 12 7 (2006) 1431-1438